Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition
- DOI
- 10.1186/s40425-019-0758-y
- Published
- 2019-10-25
- Container
- Journal for ImmunoTherapy of Cancer
- Publisher
- BMJ
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s40425-019-0758-y,
title = {Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition},
author = {Wendy Mao and Ali Ghasemzadeh and Zachary T. Freeman and Aleksandar Obradovic and Matthew G. Chaimowitz and Thomas R. Nirschl and Emily McKiernan and Srinivasan Yegnasubramanian and Charles G. Drake},
year = {2019},
journal = {Journal for ImmunoTherapy of Cancer},
doi = {10.1186/s40425-019-0758-y},
url = {https://doi.org/10.1186/s40425-019-0758-y}
}RIS
TY - JOUR TI - Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition AU - Wendy Mao AU - Ali Ghasemzadeh AU - Zachary T. Freeman AU - Aleksandar Obradovic AU - Matthew G. Chaimowitz AU - Thomas R. Nirschl AU - Emily McKiernan AU - Srinivasan Yegnasubramanian AU - Charles G. Drake PY - 2019 JO - Journal for ImmunoTherapy of Cancer DO - 10.1186/s40425-019-0758-y UR - https://doi.org/10.1186/s40425-019-0758-y ER -
APA
Mao, W., Ghasemzadeh, A., Freeman, Z. T., Obradovic, A., Chaimowitz, M. G., Nirschl, T. R., McKiernan, E., Yegnasubramanian, S., & Drake, C. G. (2019). Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1186/s40425-019-0758-y
Source records
- crossref · retrieved 2026-11-10T13:56:35.225Z